FLGT vs NDRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FLGT Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Fulgent Genetics, Inc. Common Stock (FLGT) driven by superior Valuation, Momentum & Technical, Options & Structure while NDRA counters with relative strength in Growth & Margin. Fundamentally, FLGT trades at 7.7x Forward P/E with -37.1% operating margin (+7.5% YoY revenue) versus NDRA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, FLGT sits in BREAKOUT (13th %ile IV; Dealer Gamma Walls on Pro) against NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | FLGT Revenue | NDRA Revenue | FLGT Op. Margin | NDRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $20M | $0M | -23.7% | -146080.5% | FLGT |
| FY2019 | $30M | N/A | -1.3% | N/A | FLGT |
| FY2020 | $420M | N/A | 68.8% | N/A | FLGT |
| FY2021 | $990M | N/A | 68.1% | N/A | FLGT |
| FY2022 | $620M | N/A | 28.8% | N/A | FLGT |
| FY2023 | $290M | N/A | -67.6% | N/A | FLGT |
| FY2024 | $280M | N/A | -26.1% | N/A | FLGT |
| FY2025 | $320M | N/A | -28.2% | N/A | FLGT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FLGT | NDRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $689.0M | $6.6M | Larger Scale | FLGT |
| Trailing P/E Ratio Valuation | 7.7x | N/M | Lower Multiple | FLGT |
| Forward P/E Ratio Valuation | 7.7x | N/M | Lower Multiple | FLGT |
| Revenue Growth (YoY) Growth | +7.5% | +0.0% | Higher Growth | FLGT |
| Operating Margin (TTM) Profitability | -37.1% | 0.0% | Higher Margin | NDRA |
| Net Profit Margin Profitability | -27.5% | 0.0% | Higher Margin | NDRA |
| Return on Equity (ROE) Capital Efficiency | -8.7% | -152.0% | Higher ROE | FLGT |
| 52-Week Range Position Momentum | 60% ($13โ$31) | 37% ($3โ$7) | Stronger Trend | FLGT |
| Beta / 30D Volatility Risk Regime | 1.10ฮฒ ยท 110% Vol | 0.71ฮฒ ยท 48% Vol | Lower Realized Risk | NDRA |
| Unified Institutional Score Composite Signal | 33.3 / 100 (SELL) | 44.7 / 100 (HOLD) | Higher Composite | NDRA |